These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 618453)

  • 21. Use of inhaled nitric oxide for emergency Cesarean section in a woman with unexpected primary pulmonary hypertension.
    Decoene C; Bourzoufi K; Moreau D; Narducci F; Crepin F; Krivosic-Horber R
    Can J Anaesth; 2001 Jun; 48(6):584-7. PubMed ID: 11444454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapy of secondary pulmonary hypertension.
    Peil ML; Rubin LJ
    Heart Lung; 1986 Sep; 15(5):450-6. PubMed ID: 3639073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary hypertension in systemic lupus erythematosus: effect of vasodilators on pulmonary hemodynamics.
    Mahowald ML; Weir EK; Ridley DJ; Messner RP
    J Rheumatol; 1985 Aug; 12(4):773-7. PubMed ID: 4057200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of a new pyrazole derivative on pulmonary arterial pressure in patients with pulmonary hypertension].
    Muiesan G; Sorbini CA; Toso M; Solinas E; Petz E; Renzini V
    Cuore Circ; 1966 Dec; 50(6):317-28. PubMed ID: 5997765
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of prostacycline on pulmonary circulation in pulmonary hypertension].
    Szczeklik J; Nizankowski R; Ruzyłło W; Bijak A
    Kardiol Pol; 1984; 27(7):607-12. PubMed ID: 6392688
    [No Abstract]   [Full Text] [Related]  

  • 26. [Differences in the effect of verapamil on pulmonary circulation in primary pulmonary hypertension].
    Dubiel JP; Brzostek T; Zmudka K; Bielecki A
    Przegl Lek; 1987; 44(5):421-4. PubMed ID: 3659402
    [No Abstract]   [Full Text] [Related]  

  • 27. [Action of isoproterenol used in chronic pulmonary diseases in aerosol administration].
    Santini G
    Minerva Anestesiol; 1967 Dec; 33(12):846-8. PubMed ID: 5610001
    [No Abstract]   [Full Text] [Related]  

  • 28. [The effect of isosorbide dinitrate on the pulmonary arterial system in patients with pulmonary hypertension (author's transl)].
    Hoshino T; Handa S; Akizuki S; Hori S; Norisue H; Hori A; Fukui T
    Kokyu To Junkan; 1981 Mar; 29(3):291-5. PubMed ID: 7255981
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effects of saline load on the response to isoproterenol in normal and hypertensive subjects].
    Volpe M; Trimarco B; Ricciardelli B; Rengo F; Chiariello M; Cuocolo A; Ventriglia G; Veniero AM; Condorelli M
    Cardiologia; 1982; 27(5):453-61. PubMed ID: 6892426
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effects of vasodilators on pulmonary hypertension].
    Uotani K; Kanamori K; Fujimura M; Mifune J; Taga K; Shimizu M; Hifumi S; Takahashi Y; Azuma H; Tanaka T
    Kokyu To Junkan; 1986 Sep; 34(9):977-83. PubMed ID: 3786964
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapy of primary pulmonary hypertension with phentolamine].
    Heinrich U; Angehrn W; Steinbrunn W
    Schweiz Med Wochenschr; 1983 Jan; 113(4):145-8. PubMed ID: 6828847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of nifedipine (Corinfar) on pulmonary hypertension in chronic obstructive lung disease.
    Schauer J; Orschekowski H; Steiniger L; Winkler J; Schilling W; Harzbecker K; Evers H
    Z Erkr Atmungsorgane; 1990; 175(3):132-40. PubMed ID: 2127872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic cirrhosis associated with arterial pulmonary hypertension.
    Radulescu D; Duncea C; Donca V
    Rom J Gastroenterol; 2004 Dec; 13(4):341-3. PubMed ID: 15624034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isoproterenol aerosols.
    Segal MS; Ishikawa S
    Ann Allergy; 1975 Apr; 34(4):205-9. PubMed ID: 1124859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Isosorbide dinitrate (ISDN) in the therapy of primary pulmonary hypertension].
    Daum S; Goerg R; Schlehe H
    Prax Klin Pneumol; 1983 Feb; 37(2):67-70. PubMed ID: 6835926
    [No Abstract]   [Full Text] [Related]  

  • 36. [Monitoring and pharmacologic treatment of a patient with primary pulmonary hypertension].
    Castañón E; Martín MA; Sánchez-Burón JA; Alonso J; Fernández Miranda A; Fernández FE
    Rev Esp Anestesiol Reanim; 1996 Nov; 43(9):338-9. PubMed ID: 9005506
    [No Abstract]   [Full Text] [Related]  

  • 37. Exercise-uncovered pulmonary arterial hypertension and pharmacologic therapy: Clinical benefits.
    Park MH; Ramani GV; Kop WJ; Uber PA; Mehra MR
    J Heart Lung Transplant; 2010 Feb; 29(2):228-9. PubMed ID: 20113912
    [No Abstract]   [Full Text] [Related]  

  • 38. [Course and prognosis of primary pulmonary hypertension].
    Turina J; Wirz P; Krayenbühl HP
    Schweiz Med Wochenschr; 1977 Dec; 107(49):1825-8. PubMed ID: 929144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of tolazoline, nitroprusside, nitroglycerin, isoproterenol and hydralazine on pulmonary circulation early after heart valve replacement.
    Goenen MJ; Leenaert L; Petein M; Pouleur H; Jaumin P; Tremouroux J
    Thorac Cardiovasc Surg; 1982 Oct; 30(5):253-8. PubMed ID: 6183769
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of prostaglandin E1 (PGE1) in pulmonary hypertension due to chronic obstructive pulmonary disease (COPD).
    Meissner E; Creutzig A; Fabel H
    Prog Clin Biol Res; 1989; 301():253-7. PubMed ID: 2798450
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.